What is MobileIron?
MobileIron is software used by Partners HealthCare to manage and secure mobile devices. As part of the process to register your device to receive access to corporate resources like email and apps, you must enroll into management and install the MobileIron Go app on each device that you plan to use for business purposes.
- Provides secured access to corporate resources such as Email, Intranet websites, and Home Drive
- Ensure mobile device compliance with various Partners policies
- Provides the ability to perform a “Enterprise Wipe” that removes only MobileIron managed applications and Partners email
- Enables Partners App Catalog to distribute Enterprise apps such as Citrix Receiver, Epic Haiku, Mojo, Dropbox Enterprise, etc
Why Do I Need It?
- Enrollment of your personally owned device into MobileIron is strictly optional. However, starting in Late 2016/Early 2017, MobileIron will be required if you want to access your Partners email from a mobile device
- Enterprise Apps such as Haiku, Dropbox Enterprise, Imprivata Cortext, and Mojo will only be made available through MobileIron
- With MobileIron and iOS, you will be able to access your Home Drive and internal websites from your iPhone/iPad without using a separate VPN. VPN access will be provided through MobileIron Tunnel
- Epic Haiku Users will be required to enroll their devices in MobileIron in order to remain compliant with Partners policies
What Partners Can See and What Partners Can’t See
Partners HealthCare takes its responsibility to protect your privacy very seriously. You may be understandably concerned about the level of access and control that the company gains over your device when you enroll with MobileIron. We developed this document to address those concerns and provide information on the steps we take to ensure your privacy is protected:
The Center for Genomic Medicine (CGM) comprises one of the largest and most vibrant hubs of genomic medicine research in the world. The CGM includes 46 faculty collaborating to define the ‘genomic medicine cycle’ – which envisages a genomics community seeking to advance research from basic genomics research to ultimately using genome information for diagnostics and targeted therapeutics. All of our investigators are faculty at Harvard Medical School, and many members of our community are also investigators at the Broad Institute of Harvard and MIT.
